MedPath

Evaluation of Novel Antimicrobial Hand Towels

Phase 2
Completed
Conditions
Fever
Diarrheal Diseases
Acute Respiratory Infections
Skin Infection
Interventions
Other: Antimicrobial Hand Towel
Registration Number
NCT02512614
Lead Sponsor
Centers for Disease Control and Prevention
Brief Summary

In March 2012, the investigators initiated a prospective, cluster-randomized, controlled field trial in Kisumu County, located in an area in western Kenya which has the highest under-five mortality rate in Kenya with 149 childhood deaths per 1,000 live births 9. The study was designed to evaluate the effectiveness of an antimicrobial hand towel (hereafter referred to as towel) in preventing diarrheal diseases, acute respiratory infections, self-reported fever, and skin infections in children \<2 years old.

Detailed Description

In March 2012, the investigators initiated a prospective, cluster-randomized, controlled field trial in Kisumu County, located in an area in western Kenya which has the highest under-five mortality rate in Kenya with 149 childhood deaths per 1,000 live births 9. The study was designed to evaluate the effectiveness of an antimicrobial hand towel (hereafter referred to as towel) in preventing diarrheal diseases, acute respiratory infections (ARIs), self-reported fever, and skin infections in children \<2 years old.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
449
Inclusion Criteria
  • Mother of a child <2 years old
Exclusion Criteria
  • Inaccessible enumeration area in the rainy season
  • Multiple eligible children in a single compound
  • Moved between census and round 1

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionAntimicrobial Hand TowelHand hygiene education and 4 antimicrobial hand towels
Primary Outcome Measures
NameTimeMethod
Number of participants with diarrheal diseaseWithin 48 hours of enrollment

The number of participants that experience 3 or more loose or watery stools

Secondary Outcome Measures
NameTimeMethod
Number of participants with a subjective feverWithin 48 hours of enrollment
Number of participants with respiratory infectionsWithin 48 hours of enrollment
Number of participants with a skin infectionWithin 48 hours of enrollment
© Copyright 2025. All Rights Reserved by MedPath